Betamethasone Valerate/ Neomycin
Corticosteroid
What it is used for
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Clinical selection for Betamethasone Valerate/ Neomycin should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Corticosteroid. Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Limit use in children or on face to maximum of 5 days. It should be withdrawn gradually following prolonged therapy. Unless fully unavoidable, potent corticosteroids should not be used on the face as they may precipitate a rosacea-like disorder and aggravate any pre-existing rosacea, avoid use in an occluded area, near the eye, use in the presence of skin infections without concomitant use of anti-microbial, children under 1yr, on weeping foci.
Possible side effects
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.
Storage
HOW SUPPLIED Product: 50090-1647 NDC: 50090-1647-0 15 g in a TUBE / 1 in a CARTON
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.